发明授权
- 专利标题: Antisense compound for inducing immunological tolerance
- 专利标题(中): 用于诱导免疫耐受性的反义化合物
-
申请号: US11941033申请日: 2007-11-15
-
公开(公告)号: US08008469B2公开(公告)日: 2011-08-30
- 发明人: Dan V. Mourich , Hong M. Moulton , David J. Hinrichs , Patrick L. Iversen
- 申请人: Dan V. Mourich , Hong M. Moulton , David J. Hinrichs , Patrick L. Iversen
- 申请人地址: US OR Corvallis
- 专利权人: AVI BioPharma Inc.
- 当前专利权人: AVI BioPharma Inc.
- 当前专利权人地址: US OR Corvallis
- 代理机构: Seed IP Law Group PLLC
- 主分类号: C07H21/02
- IPC分类号: C07H21/02 ; C07H21/04 ; C12Q1/68 ; A61K31/70
摘要:
A method and conjugate for selectively killing antigen-activated T cells are disclosed. The conjugate is composed of a substantially uncharged antisense compound targeted against the human cFLIP protein, and a reverse TAT (rTAT) polypeptide coupled covalently to the antisense compound. The rTAT polypeptide is effective to produce selective uptake of the conjugate into antigen-activated T cells, relative to the uptake of the conjugate into non-activated T cells. The cFLIP antisense compound causes activation induced cell death (AICD) of activated lymphocytes. The method is useful in treating transplantation rejection and autoimmune conditions.
公开/授权文献
- US20090111977A1 ANTISENSE COMPOUND FOR INDUCING IMMUNOLOGICAL TOLERANCE 公开/授权日:2009-04-30
信息查询